Predictive Factors for Treatment Response in Patients With Newly-diagnosed Polymyalgia Rheumatica and Giant Cell Arteritis
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY
This prospective study is to explore different predictive factors for response to steroid treatment in patients with PMR and/or GCA. It evaluates the association of endogenous GC suppression (plasma and urinary cortisol and cortisone) to the responsiveness of PMR/GCA to GCs.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
View:
• Patients with diagnosis of PMR according to the 2012 provisional classification criteria and GCA according to published criteria
• Consent to participate in the SCQM database
• Treatment according to our standardized regimes
Locations
Other Locations
Switzerland
Department of Rheumatology University Hospital Basel
RECRUITING
Basel
Contact Information
Primary
Thomas Daikeler, Prof. Dr. med.
Thomas.Daikeler@usb.ch
+41 61 265 27 09
Time Frame
Start Date: 2022-06-03
Estimated Completion Date: 2028-12
Participants
Target number of participants: 30
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Basel, Switzerland
Collaborators: Schweizerische Stiftung für die Erforschung der Muskelkrankheiten, Novartis